26.06.2013 - Japanese drugmaker Eisai is to stop selling its new epilepsy therapy Fycompa in Germany - the biggest market for the product - following a row over the price it can charge for the...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)